Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Sep 23, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how transgender veterans access and receive gender-affirming treatments (GATs), which are important medical care options that help reduce the distress some individuals feel when their gender identity doesn’t match their birth sex. The study aims to discover what types of GATs transgender veterans are receiving, the challenges they face in getting these treatments through the VA (Veterans Affairs) and community care, and how to improve access to these necessary services. By working with a group of stakeholders, the researchers hope to create strategies that will help overcome barriers and enhance support for transgender veterans seeking GATs.
To participate in this study, veterans need to have a documented diagnosis of gender identity disorder and identify as transgender. There are no specific exclusions, meaning anyone who meets these criteria can join. Participants can expect to share their experiences and insights, which will help shape better access to gender-affirming care in the future. This research is important in promoting health equity for transgender veterans, ensuring they receive the care they need and deserve.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All veterans with documentation of gender identity disorder diagnoses
- • Self-reported gender identity as transgender and relevant transgender-related health factor
- Exclusion Criteria:
- • None
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bedford, Massachusetts, United States
Patients applied
Trial Officials
Guneet K. Jasuja, PhD
Principal Investigator
VA Bedford HealthCare System, Bedford, MA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported